Testing samples from HPV vaccine trials to understand effectiveness.
Laboratory testing of biospecimens collected from participants of the NCI’s HPV Vaccine studies.
This study is looking at samples from people who have already received the HPV vaccine to see how well one dose works compared to two doses in preventing cervical cancer, and the findings will help improve future vaccination strategies for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fundacion Inciensa NIH-funded |
| Lab location | 1 site (San Jose, Costa Rica) |
| Project ID | NIH-11220592 on NIH RePORTER |
What this research studies
This research focuses on analyzing biospecimens collected from participants in clinical trials that are evaluating the effectiveness of one versus two doses of HPV vaccines in preventing cervical cancer. The samples will be tested using advanced genetic sequencing techniques in a certified laboratory in Costa Rica. By examining these samples, researchers aim to gather important data that could inform future vaccination strategies and improve public health outcomes related to HPV. Participants in the trials have already received the HPV vaccine, and their samples will help assess the vaccine's performance.
Who could benefit from this research
Good fit: Ideal candidates for this research are adult women who have participated in the NCI's HPV vaccine trials.
Not a fit: Patients who have not participated in the HPV vaccine trials or who are not adult women may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies that enhance the prevention of cervical cancer in women.
How similar studies have performed: Previous research has shown success in using genetic sequencing to evaluate vaccine effectiveness, making this approach promising.
Where this research is happening
San Jose, Costa Rica
- Fundacion Inciensa — San Jose, Costa Rica (Active)
Researchers
- Principal investigator: Porras, Carolina — Fundacion Inciensa
- Study coordinator: Porras, Carolina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.